Maven Brands - CEO, Darcy Bomford.
CEO, Darcy Bomford.
Source: Maven Brands.
  • Maven Brands (MJ) has closed the first tranche of a previously announced non-brokered private placement for gross proceeds of $242,359.56
  • The company issued 1,346,442 units exerciseable for two years
  • Proceeds will be used to complete work for the launch of the company’s craft cannabis processing program
  • Maven Brands is a licensed cannabis producer preparing to launch a program to provide path-to-market services for micro-cultivators
  • Maven Brands Inc. (MJ) opened trading at C$0.21 per share

Maven Brands (MJ) has closed the first tranche of a non-brokered private placement for gross proceeds of $242,359.56.

The company issued 1,346,442 units. Each unit consists of one common share and one-half of one warrant, with each whole warrant exercisable to purchase one additional common share at a price of $0.27 for a period of two years.

Maven Brands paid $6,004.80 in cash commissions and 33,360 finder’s warrants.

Proceeds will be used to complete work for the launch of the company’s craft cannabis processing program and for general corporate purposes.

Maven is a licensed producer of cannabis preparing to launch a program to provide path-to-market services for micro-cultivators. The program will offer a full suite of in-house processing services to the craft cannabis community.

Maven Brands Inc. (MJ) opened trading at C$0.21 per share.

More From The Market Online
Cannabis Report image of farmed cannabis plants

StockTalk | Cannabis Report: Quarterly report season heats up

Vertically-integrated producer of premium-grade cannabis products, Cannara Biotech Inc. reported gross cannabis revenues before excise taxes...
Cannabis Report across cannabis plants

StockTalk | Cannabis Report: Shake-ups

MediPharm Labs announced that chief executive officer, David Pidduck will step down from his role, effective January...

Buzz on the Bullboards: As Arctic tensions flare, investors eye three news‑making stocks

Global markets opened the week on edge as a fresh rift between Washington and key NATO...

MediPharm Labs announces CEO transition as David Pidduck steps down

MediPharm Labs (TSX:LABS) CEO David Pidduck will step down on January 23, 2026, and will remain on the Board to support the transition.